Publications by authors named "Michael Humphries"

Claim this Profile
A
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status.
Lyudmila Bazhenova, J G Hodgson, D Ross Camidge, Corey J Langer, Rudolf M Huber, Michael J Humphries

Clin Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ziresovir in hospitalised infants aged 6 months or younger with respiratory syncytial virus infection in China: findings from a phase 3 randomised trial with 24-month follow-up.
Han Zhang, Wei Zhao, Xiaoyan Zhang, Lei Zhang, Run Guo, Michael Humphries

Lancet Child Adolesc Health· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world ALK Testing Trends in Patients With Advanced Non-Small-Cell Lung Cancer in the United States.
Huamao M Lin, Yanyu Wu, Yu Yin, Huifeng Niu, Eileen A Curran, Michael J Humphries

Clin Lung Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians.
Jing Li, Jing Yang, Lingfei Kong, Yijiang Huang, Ping Chen, Michael Humphries

Asian Pac J Allergy Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of brigatinib in adult patients with ALK inhibitor-naive ALK-positive non-small cell lung cancer from a US perspective.
Holly Cranmer, Isabella Kearns, Melanie Young, Michael J Humphries, David Trueman

J Manag Care Spec Pharm· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catching the GIST: Massive Gastrointestinal Stromal Tumor Presenting as Acute Dyspnea.
Hytham Rashid, Johnathon Chung, Mimi Phan Haghshenas, Michael Harrison Humphries, Sivatej Sarva

J Radiol Case Rep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing and Duration of Sleep in Hospitalized Children: An Observational Study.
Ellen L Cowherd, Ashley G Sutton, Jennifer O Vincent, Michael S Humphries, Victor Ritter

Hosp Pediatr· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.
Jadwiga A Wedzicha, Nanshan Zhong, Masakazu Ichinose, Michael Humphries, Robert Fogel

Int J Chron Obstruct Pulmon Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis.
Claus Vogelmeier, Nanshan Zhong, Michael J Humphries, Karen Mezzi, Robert Fogel

Int J Chron Obstruct Pulmon Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Indacaterol/Glycopyrronium (IND/GLY) Versus Salmeterol/Fluticasone in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: The Chinese Cohort from the LANTERN Study.
Nanshan Zhong, Changzheng Wang, Xiangdong Zhou, Nuofu Zhang, Michael Humphries

COPD· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study.
Jing Li, Jian Kang, Changzheng Wang, Jing Yang, Linda Wang, Michael Humphries

Allergy Asthma Immunol Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
Nanshan Zhong, Changzheng Wang, Xiangdong Zhou, Nuofu Zhang, Michael Humphries

Int J Chron Obstruct Pulmon Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.
Chen Wang, Tieying Sun, Yijiang Huang, Michael Humphries, Lingyan Bai

Int J Chron Obstruct Pulmon Dis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salmeterol/Fluticasone Propionate in a Single Inhaler is Superior to Budesonide Alone in Control of Chinese Asthmatic Adults : An Open-Label, Randomised, 6-Week Study.
Nan Shan Zhong, Zheng Jin Ping, Michael J Humphries, Du Xin

Clin Drug Investig· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulated binding of importin-α to protein kinase Cδ in response to apoptotic signals facilitates nuclear import.
Tariq S Adwan, Angela M Ohm, David N M Jones, Michael J Humphries, Mary E Reyland

J Biol Chem· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-agent inhibition of Chk1 is antiproliferative in human cancer cell lines in vitro and inhibits tumor xenograft growth in vivo.
Kurtis D Davies, Michael J Humphries, Francis X Sullivan, Ira von Carlowitz, Yvan Le Huerou

Oncol Res· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of apoptosis is driven by nuclear retention of protein kinase C delta.
Tracie A DeVries-Seimon, Angela M Ohm, Michael J Humphries, Mary E Reyland

J Biol Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of apoptosis in the protein kinase Cdelta null mouse in vivo.
Michael J Humphries, Kirsten H Limesand, Jonathan C Schneider, Keiichi I Nakayama, Steven M Anderson

J Biol Chem· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of cell migration by protein kinase Cdelta.
Desmond Jackson, Yang Zheng, Donggon Lyo, Yinjie Shen, Keiko Nakayama, Michael J Humphries

Oncogene· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis